felodipine has been researched along with Hypertension, Essential in 3 studies
Felodipine: A dihydropyridine calcium antagonist with positive inotropic effects. It lowers blood pressure by reducing peripheral vascular resistance through a highly selective action on smooth muscle in arteriolar resistance vessels.
felodipine : The mixed (methyl, ethyl) diester of 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid. A calcium-channel blocker, it lowers blood pressure by reducing peripheral vascular resistance through a highly selective action on smooth muscle in arteriolar resistance vessels. It is used in the management of hypertension and angina pectoris.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study aimed to analyze the effect of felodipine combined with enalapril in the treatment of patients with essential hypertension and coronary artery disease." | 9.51 | Efficacy of felodipine and enalapril in the treatment of essential hypertension with coronary artery disease and the effect on levels of Salusin-β, Apelin, and PON1 gene expression in patients. ( Jin, F; Zhang, J; Zhang, W; Zhou, H, 2022) |
| "To assess the efficacy and safety of aranidipine versus retard-released felodipine in Chinese patients with mild-to-moderate essential hypertension." | 9.17 | [Efficacy and safety of aranidipine in Chinese patients with mild-to-moderate essential hypertension]. ( Chen, L; Jiao, Y; Jin, H; Ke, YN; Li, DY; Liu, MX; Wang, BY; Wang, L; Wang, Y; Yang, HY; Zhao, XL; Zheng, JT, 2013) |
| "The current study addresses the 24-h antihypertensive efficacy and safety of arotinolol combined with a different calcium channel blocker." | 6.79 | The efficacy and safety of arotinolol combined with a different calcium channel blocker in the treatment of Chinese patients with essential hypertension: a one-year follow-up study. ( Chen, W; Fang, H; Liu, X; Xu, W, 2014) |
| "This study aimed to analyze the effect of felodipine combined with enalapril in the treatment of patients with essential hypertension and coronary artery disease." | 5.51 | Efficacy of felodipine and enalapril in the treatment of essential hypertension with coronary artery disease and the effect on levels of Salusin-β, Apelin, and PON1 gene expression in patients. ( Jin, F; Zhang, J; Zhang, W; Zhou, H, 2022) |
| "To assess the efficacy and safety of aranidipine versus retard-released felodipine in Chinese patients with mild-to-moderate essential hypertension." | 5.17 | [Efficacy and safety of aranidipine in Chinese patients with mild-to-moderate essential hypertension]. ( Chen, L; Jiao, Y; Jin, H; Ke, YN; Li, DY; Liu, MX; Wang, BY; Wang, L; Wang, Y; Yang, HY; Zhao, XL; Zheng, JT, 2013) |
| "The current study addresses the 24-h antihypertensive efficacy and safety of arotinolol combined with a different calcium channel blocker." | 2.79 | The efficacy and safety of arotinolol combined with a different calcium channel blocker in the treatment of Chinese patients with essential hypertension: a one-year follow-up study. ( Chen, W; Fang, H; Liu, X; Xu, W, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, W | 1 |
| Zhang, J | 1 |
| Jin, F | 1 |
| Zhou, H | 1 |
| Jiao, Y | 1 |
| Chen, L | 1 |
| Zheng, JT | 1 |
| Ke, YN | 1 |
| Wang, Y | 1 |
| Yang, HY | 1 |
| Jin, H | 1 |
| Zhao, XL | 1 |
| Liu, MX | 1 |
| Wang, L | 1 |
| Wang, BY | 1 |
| Li, DY | 1 |
| Fang, H | 1 |
| Chen, W | 1 |
| Liu, X | 1 |
| Xu, W | 1 |
3 trials available for felodipine and Hypertension, Essential
| Article | Year |
|---|---|
Efficacy of felodipine and enalapril in the treatment of essential hypertension with coronary artery disease and the effect on levels of Salusin-β, Apelin, and PON1 gene expression in patients.
Topics: Apelin; Aryldialkylphosphatase; Blood Pressure; Coronary Artery Disease; Enalapril; Essential Hypert | 2022 |
[Efficacy and safety of aranidipine in Chinese patients with mild-to-moderate essential hypertension].
Topics: Antihypertensive Agents; Dihydropyridines; Double-Blind Method; Essential Hypertension; Felodipine; | 2013 |
The efficacy and safety of arotinolol combined with a different calcium channel blocker in the treatment of Chinese patients with essential hypertension: a one-year follow-up study.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Amlodipine; Anti | 2014 |